Cargando…

Safety of Accelerated Schedules of Subcutaneous Allergen Immunotherapy with House Dust Mite Extract in Patients with Atopic Dermatitis

The safety of accelerated schedules of allergen immunotherapy (ASAI) in patients with bronchial asthma (BA) has been reported but there are little data on the safety of ASAI for patients with atopic dermatitis (AD). In this study, we investigated the safety of ASAI in patients with AD. Sixty patient...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Myoung-Eun, Kim, Jeong-Eun, Sung, Joon-Mo, Lee, Jin-Woo, Choi, Gil-Soon, Nahm, Dong-Ho
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Academy of Medical Sciences 2011
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3172652/ https://www.ncbi.nlm.nih.gov/pubmed/21935270 http://dx.doi.org/10.3346/jkms.2011.26.9.1159

Ejemplares similares

Safety of Ultra-rush Schedule of Subcutaneous Allergen Immunotherapy With House Dust Mite Extract Conducted in an Outpatient Clinic in Patients With Atopic Dermatitis and Allergic Rhinitis
por: Lee, So-Hee, et al.
Publicado: (2019)

Treatment of Severe Atopic Dermatitis with a Combination of Subcutaneous Allergen Immunotherapy and Cyclosporin
por: Nahm, Dong-Ho, et al.
Publicado: (2012)

Clinical Efficacy of Subcutaneous Allergen Immunotherapy in Patients with Atopic Dermatitis
por: Nahm, Dong-Ho, et al.
Publicado: (2016)

The Effectiveness of Allergen Immunotherapy in Adult Patients with Atopic Dermatitis Allergic to House Dust Mites
por: Bogacz-Piaseczyńska, Agnieszka, et al.
Publicado: (2022)

Treatment of Patients with Refractory Atopic Dermatitis Sensitized to House Dust Mites by Using Sublingual Allergen Immunotherapy
por: Choi, Joon-Seok, et al.
Publicado: (2015)

The Indoor Level of House Dust Mite Allergen Is Associated with Severity of Atopic Dermatitis in Children
por: Kim, Jihyun, et al.
Publicado: (2013)

A Retrospective Study of Clinical Response Predictors in Subcutaneous Allergen Immunotherapy With House Dust Mites for Allergic Rhinitis
por: Lee, Ji-Ho, et al.
Publicado: (2018)

Effect of indoor house dust mite concentration on canine atopic dermatitis
por: Kim, Jihee, et al.
Publicado: (2023)

House dust mite sensitisation and association with atopic dermatitis in Brunei: Allergen sensitization and allergic disease in Brunei
por: Emran, Haziq, et al.
Publicado: (2019)

Variation in allergen content in sublingual allergen immunotherapy with house dust mites
por: Moreno Benítez, F., et al.
Publicado: (2015)

House Dust Mite Prevalence in the House of Patients with Atopic Dermatitis in Mashhad, Iran
por: Ziyaei, Toktam, et al.
Publicado: (2017)

Molecular profiling of allergen-antibody IgE might decide about the efficacy of allergen immunotherapy in a patient with atopic dermatitis and allergy to house dust mites
por: Bogacz-Piaseczyńska, Agnieszka, et al.
Publicado: (2023)

Allergen immunotherapy for house dust mite-induced rhinitis: prescriptive criteria
por: Incorvaia, Cristoforo, et al.
Publicado: (2021)

Changes in skin reactivity and associated factors in patients sensitized to house dust mites after 1 year of allergen-specific immunotherapy
por: Son, Jeong-Yeop, et al.
Publicado: (2017)

Retrospective evaluation of adverse reactions after subcutaneous allergen-specific immunotherapy in children with house dust mite allergy
por: Altas, Ugur, et al.
Publicado: (2023)

Protective effect of the DNA vaccine encoding the major house dust mite allergens on allergic inflammation in the murine model of house dust mite allergy
por: Kim, Nacksung, et al.
Publicado: (2006)

Anti-atopic dermatitis effect of fish collagen on house dust mite-induced mice and HaCaT keratinocytes
por: Kim, Hye-Min, et al.
Publicado: (2023)

Retrospective Analysis on the Effects of House Dust Mite Specific Immunotherapy for More Than 3 Years in Atopic Dermatitis
por: Lee, Jungsoo, et al.
Publicado: (2016)

Comparison of the presentation of atopic dermatitis induced by trinitrochlorobenzene and house dust mite in NC/Nga mice
por: Kim, Yoon-Hwan, et al.
Publicado: (2020)

Non-IgE-reactive allergen peptides deteriorate the skin barrier in house dust mite-sensitized atopic dermatitis patients
por: Pfisterer, Karin, et al.
Publicado: (2023)

Toxoplasma gondii Infection Suppresses House Dust Mite Extract-Induced Atopic Dermatitis in NC/Nga Mice
por: Jeong, Young-Il, et al.
Publicado: (2015)

Forsythia suspensa Suppresses House Dust Mite Extract-Induced Atopic Dermatitis in NC/Nga Mice
por: Sung, Yoon-Young, et al.
Publicado: (2016)

Immunotherapy of house dust mite allergy
por: Yang, Lin, et al.
Publicado: (2017)

Variability of house dust mite allergen exposure in dwellings.
por: Hirsch, T, et al.
Publicado: (1998)

Allergens with Protease Activity from House Dust Mites
por: Reithofer, Manuel, et al.
Publicado: (2017)

Requirements for acquiring a high-quality house dust mite extract for allergen immunotherapy
por: Frati, Franco, et al.
Publicado: (2012)

In Vitro Evaluation of Allergen Potencies of Commercial House Dust Mite Sublingual Immunotherapy Reagents
por: Park, Kyung Hee, et al.
Publicado: (2015)

The usefulness of the basophil activation test in monitoring specific immunotherapy with house dust mite allergens
por: Czarnobilska, Ewa M., et al.
Publicado: (2018)

Clinical evaluation of rush immunotherapy using house dust mite allergen in Japanese asthmatics
por: Uchida, Takahiro, et al.
Publicado: (2021)

Comparing the results of intradermal skin tests for four dust mite allergens in dogs with atopic dermatitis in Thailand
por: Chermprapai, Suttiwee, et al.
Publicado: (2020)

New approaches to immunotherapy in house dust mite allergy
por: Kim, In Sik
Publicado: (2022)

Characteristics and management of sublingual allergen immunotherapy in children with allergic rhinitis and asthma induced by house dust mite allergens
por: Trebuchon, Florence, et al.
Publicado: (2014)

Regulation of Constitutive Neutrophil Apoptosis Due to House Dust Mite Allergen in Normal and Allergic Rhinitis Subjects
por: Kim, Eun Hye, et al.
Publicado: (2014)

Safety of house dust mite subcutaneous immunotherapy in preschool children with respiratory allergic diseases
por: Yang, Yaqi, et al.
Publicado: (2021)

House Dust Mite Subcutaneous Immunotherapy and Lung Function Trajectory in Children and Adolescents with Asthma
por: Nogami, Kazutaka, et al.
Publicado: (2022)

Comparison of Allergenic Properties among Commercially Available House Dust Mite Allergen Extracts in Korea
por: Kim, Ji Tae, et al.
Publicado: (2021)

Immune response to allergens in sheep sensitized to house dust mite
por: Bischof, Robert J, et al.
Publicado: (2008)

Update on House Dust Mite Allergen Avoidance Measures for Asthma
por: Zuiani, Chiara, et al.
Publicado: (2020)

Erratum: In Vitro Evaluation of Allergen Potencies of Commercial House Dust Mite Sublingual Immunotherapy Reagents
por: Park, Kyung Hee, et al.
Publicado: (2017)

Molecular Profile Sensitization to House Dust Mites as an Important Aspect for Predicting the Efficiency of Allergen Immunotherapy
por: Rodinkova, Victoria V., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_i3krp79kkm3u1lilhr3p0iomf0